Company: EDSA
Filing Date: 2025-07-25
Form Type: S-3
Source: 0001171843-25-004721
Chunk: 29

Company: Edesa Biotech, Inc.
Filing Date: 2025-07-25
Form: S-3
Chunk 29
---
, including:

| · | the name or names of any underwriters, dealers or agent; |

| · | the purchase price of the offered securities and the proceeds to us from such sale; |

| · | any underwriting discounts and commissions or agency fees and other items constituting underwriters’ 
 or agents’ compensation;                                                                             |

| · | any initial public offering price and any discounts or concessions allowed or reallowed or paid to dealers; |

| · | any securities exchange on which such offered securities may be listed; and |

| · | any underwriter, agent or dealer involved in the offer and sale of any series of the securities. |

The distribution of the securities may be effected from time to time in one or more transactions:

| · | at fixed prices, which may be changed; |

| · | at market prices prevailing at the time of the sales; |

| · | at varying prices determined at the time of sale; or |

| · | at negotiated prices. |

Each prospectus supplement will set forth the manner and terms of an offering of securities including:

| · | whether that offering is being made to underwriters, through agents or directly to the public; |

| · | the rules and procedures for any auction or bidding process, if used; |

| · | the securities’ purchase price or initial public offering price; and |

| · | the proceeds we anticipate from the sale of the securities, if any. |

In addition, we may enter into derivative or hedging transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. The applicable prospectus supplement may indicate, in connection with such a transaction, that the third parties may sell securities covered by and pursuant to this prospectus and an applicable prospectus supplement. If so, the third party may use securities pledged by us or borrowed from us or others to settle such sales and may use securities received from us to close out any related short positions. We may also loan or pledge securities covered by this prospectus and an applicable prospectus supplement to third parties, who may sell the loaned securities or, in an event of default in the case of a pledge, sell the pledged securities pursuant to this prospectus and the applicable prospectus supplement.

| 22 |

Sales Through Underwriters

If underwriters are used in the sale of some or all of the securities covered by this prospectus, the underwriters will acquire the securities for their own account. The underwriters may resell the securities, either directly